About: Combination chemotherapy (CMFVP) versus L-phenylalanine mustard (L-PAM) for operable breast cancer with positive axillary nodes: a Southwest Oncology Group Study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Combination chemotherapy (CMFVP) versus L-phenylalanine mustard (L-PAM) for operable breast cancer with positive axillary nodes: a Southwest Oncology Group Study Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 August 1982

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 1982 (uk) im August 1982 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'agostu de 1982 (ast) scientific article published on 01 August 1982 (en)
publication date	wds:Q70245493-90A208BB-72B3-4A1B-856C-DCE5138BB588
publication date	1982-08-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q70245493-E745E505-233A-44AB-92E9-F6CA77FC710B
language of work or name	English
author name string	wds:Q70245493-23329DD1-0D24-454E-94F6-3F4B54C9AE04 wds:Q70245493-5CCBDBBF-4C32-4833-8F4B-C17C479E0700 wds:Q70245493-754CA0C7-AC21-4B29-B10A-2D5C16DBB7EC wds:Q70245493-8DFBFDCF-9EDA-4F13-B556-EFA18DC201F5 wds:Q70245493-8E8FAFF7-8113-4597-AA42-6064A6E72C05 wds:Q70245493-951406D7-3442-4644-ABBA-0FABB37678BD wds:Q70245493-AFB63CD9-747A-490F-B015-CD9D09F9E917 wds:Q70245493-B3EA92C2-F9CE-4EAA-B50C-55C0E6F1200B wds:Q70245493-C064A27D-85FB-4224-AB1E-4F1B23ECF649 wds:Q70245493-C9B07A63-BE74-4569-B541-8B8FFAF4A345 wds:Q70245493-D5E67ECE-5EEE-44C6-9382-4554EA0CF8BF
author name string	S Rasmussen N Gad-el-Mawla C Vaughn S E Rivkin J Athens J McCracken B Hoogstraten H Glucksberg T Maloney J Costanzi B Tranum
rdfs:label	Combination chemotherapy (CMFVP) versus L-phenylalanine mustard (L-PAM) for operable breast cancer with positive axillary nodes: a Southwest Oncology Group Study (en) Combination chemotherapy (CMFVP) versus L-phenylalanine mustard (L-PAM) for operable breast cancer with positive axillary nodes: a Southwest Oncology Group Study (nl)
skos:prefLabel	Combination chemotherapy (CMFVP) versus L-phenylalanine mustard (L-PAM) for operable breast cancer with positive axillary nodes: a Southwest Oncology Group Study (en) Combination chemotherapy (CMFVP) versus L-phenylalanine mustard (L-PAM) for operable breast cancer with positive axillary nodes: a Southwest Oncology Group Study (nl)
name	Combination chemotherapy (CMFVP) versus L-phenylalanine mustard (L-PAM) for operable breast cancer with positive axillary nodes: a Southwest Oncology Group Study (en) Combination chemotherapy (CMFVP) versus L-phenylalanine mustard (L-PAM) for operable breast cancer with positive axillary nodes: a Southwest Oncology Group Study (nl)
title	wds:Q70245493-F3CB6430-A486-48E6-8A6D-1EF52C3F5BA1
title	Combination chemotherapy (CMFVP) versus L-phenylalanine mustard (L-PAM) for operable breast cancer with positive axillary nodes: a Southwest Oncology Group Study (en)
page(s)	wds:Q70245493-1F0CC8F6-1A83-43D8-A629-706E442F2260
page(s)	423-434
instance of	wds:Q70245493-56DEC753-0A67-4D46-B9C3-8618698AC2CF
instance of	scholarly article
PubMed ID	wds:Q70245493-E586BFE1-A520-4934-9A34-31B588F968B7
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7046900
PubMed ID	7046900
published in	wds:Q70245493-8F0F4381-FA66-4694-871A-DEAD304FC91E
published in	Cancer
issue	wds:Q70245493-D4226581-1AC0-4137-8FA9-A4630C8B5998
volume	wds:Q70245493-E7BB1681-9D7D-4E84-ABA9-4756044736A3
issue	3
volume	50
number of pages	wds:Q70245493-1D69A021-C499-4FC5-85EB-B8CA81F10B7E
number of pages	12 (xsd:decimal)
DOI	wds:Q70245493-71DC9A6F-F814-4C14-A7FF-6D21B7E66F17
DOI	http://dx.doi.org/10.1002/1097-0142(19820801)50:3%3C423::AID-CNCR2820500307%3E3.0.CO;2-O
DOI	10.1002/1097-0142(19820801)50:3<423::AID-CNCR2820500307>3.0.CO;2-O
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q70245493
is cites work of	The Exponential-Gompertzian Tumor Growth Model: Data from Six Tumor Cell Lines in Vitro and in Vivo. Estimate of the Transition point from Exponential to Gompertzian Growth and Potential Cinical Implications The psychological dimension in cancer treatment Haematological toxicity: a marker of adjuvant chemotherapy efficacy in stage II and III breast cancer Leucocyte nadir as a marker for chemotherapy efficacy in node-positive breast cancer treated with adjuvant CMF CONTROLLED TRIAL OF ADJUVANT CHEMOTHERAPY WITH MELPHALAN FOR BREAST CANCER Adjuvant chemotherapy of breast cancer: hope--reality--hazard? Adjuvant therapy in primary breast cancer Chemotherapy of breast cancer Adjuvant chemotherapy of cancer. A review of its current status Postmastectomy adjuvant chemotherapy with or without radiation therapy in women with operable breast cancer and positive axillary lymph nodes: the Southeastern Cancer Study Group experience Adjuvant chemotherapy in stage-II breast cancer: An overview of the NSABP clinical trials The Effect of Positive SWOG Treatment Trials on Survival of Patients With Cancer in the US Population Adjuvant systemic therapy in breast cancer; a review Thymidine labeling index in breast tumors Breast cancer: the new biology in conflict with the old dogma Surgical adjuvant treatment of locally advanced breast cancer Current status of chemotherapy of breast cancer Status of adjuvant chemotherapy in patients with breast cancer Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year resu Adjuvant therapy of breast cancer: The Southwest Oncology Group experience Adjuvant chemotherapy for operable breast cancer with positive axillary nodes: a comparison of CMFVP versus L-PAM Adjuvant therapy for breast cancer with positive axillary nodes designed according to estrogen receptor status Systemic therapy of breast cancer--1985 Choosing treatment for metastatic breast cancer Systemic adjuvant therapy and breast cancer
is cites work of	wds:Q36620540-C3949636-72FF-4855-A908-3549C87AEB31 wds:Q39819152-6975CD19-C71E-4711-B5C1-DF4FDBEFAF62 wds:Q40204754-4EF90FC9-3E27-4B91-9D7C-235C6E1699C7 wds:Q39733754-CBDF0F98-A814-4B95-B135-60CC9F7DFE08 wds:Q31162507-F260938D-D3D9-42BD-BB45-C752154FA198 wds:Q40168061-DE7CF92B-08E0-4E22-A3F2-B579F758B825 wds:Q67659498-C21623C3-8E3F-48D7-A1DE-A722F9B9F5C0 wds:Q69820645-E0F13DF4-D843-43EB-BE90-613B065218F1 wds:Q40184481-D2CDB7EE-2818-4D58-B316-2B0BD63C341B wds:Q43885417-450147EA-3A07-424D-B33E-4C7227E9C58D wds:Q70330900-5CEAD255-5696-4A68-846F-F3333868422C wds:Q70313307-53B92802-983A-42DF-BE53-36CC917C8C26 wds:Q70330917-7FF4A441-F134-4750-A5F4-119C65FC7A5F wds:Q36115998-7AF1CD3E-DC23-4C42-9975-FF703DD6F2A4 wds:Q44255513-2BA43B76-FC9C-41BE-B67C-AAC1EBBDED54 wds:Q69805368-2515C1B1-1FF0-4847-97CA-3379C48D3C34

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software